FDA Issues First Draft Guidance on Clinical Trials With Psychedelic Drugs
Health
FDA Issues First Draft Guidance on Clinical Trials With Psychedelic Drugs
2023-06-23 17:29:41
by Dan McCue

WASHINGTON — The Food and Drug Administration on Friday published a new draft guidance on what researchers should consider when investigating the use of psychedelic drugs for potential treatment of medical conditions, including psychiatric or substance use disorders.  The first-of-its-kind... Read More

Straight From The Well
scroll top